Hematolic drugs

(±)-Catechin hydrate.

(±)-CP 55，940.

(±)-U-50488 hydrochloride.

(±)12-HEPE Produced by non-enzymatic oxidation of EPA, where it contains a racemic mixture. The biological activity is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet

(±)12-HEPE Produced by non-enzymatic oxidation of EPA, where it contains a racemic mixture. The biological activity is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet

(±)12-HEPE Produced by non-enzymatic oxidation of EPA, where it contains a racemic mixture. The biological activity is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet

(±)12-HEPE Produced by non-enzymatic oxidation of EPA, where it contains a racemic mixture. The biological activity is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet

(Al,As,B,Ba,Be,Bi,Cd,Co,Cr,Cu,Fe,Ga,Li,Mg,Mn,Ni,Pb,Sb,Sn,Sr,Ti,Tl,V,Zn ）Mix.

(Boc-Cys-OH)2

Legal Information Sold under license from Rhodia Pharma Solutions.

(DL)-Serine hydrazide HCl.

(DL)-Serine hydrazide HCl